About CrisprBits
CrisprBits is a company based in Delhi (India) founded in 2020 by Bharat Jobanputra, Sunil Arora, Rajeev Kohli, Aditya Sarda, and Vijaya Chandru. CrisprBits has raised $3.45 million across 3 funding rounds from investors including VJ Technologies, Abilities India Pistons and Rings and Rajeev Kohli. The company has 1 employees as of April 06, 2024. CrisprBits offers products and services including CRISPR Diagnostics, Therapeutics Development, and Climate Applications. CrisprBits operates in a competitive market with competitors including Foundation Medicine, Personalis, Novogene Corporation, MedGenome and Lantern Pharma, among others.
- Headquarter Delhi, India
- Employees 1 as on 06 Apr, 2024
- Founders Bharat Jobanputra, Sunil Arora, Rajeev Kohli, Aditya Sarda, Vijaya Chandru
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Crisprbits Private Limited
- Date of Incorporation 19 Oct, 2020
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$29.62 (USD)0as on Mar 31, 2021
-
Net Profit
-$2.06 K (USD)0as on Mar 31, 2021
-
EBITDA
-$2 K (USD)0as on Mar 31, 2021
-
Total Equity Funding
$3.45 M (USD)
in 3 rounds
-
Latest Funding Round
$3 M (USD), Seed
Nov 25, 2025
-
Investors
VJ Technologies
& 9 more
-
Employee Count
1
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CrisprBits
CrisprBits offers a comprehensive portfolio of products and services, including CRISPR Diagnostics, Therapeutics Development, and Climate Applications.
Tests for infectious and inherited diseases using gene-editing technology.
Enables ex-vivo editing for CAR-T cells and iPSCs in healthcare.
Applies CRISPR for crop disease resistance and drought tolerance.
Funding Insights of CrisprBits
CrisprBits has successfully raised a total of $3.45M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CrisprBits
CrisprBits has secured backing from 10 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include VJ Technologies, Abilities India Pistons and Rings and Rajeev Kohli.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Spectrum Impact is engaged in solving societal issues through investments.
|
Locked | Locked | Locked | |
|
Provider of x-ray inspection solutions
|
Locked | Locked | Locked | |
|
Manufactures automotive pistons, rings, and casting parts for engine components.
|
Locked | Locked | Locked |
Investor details for CrisprBits
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CrisprBits
Investment portfolio details for CrisprBits
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CrisprBits
Detailed financials for CrisprBits
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crisprbits Comparisons
Peer comparison for CrisprBits
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CrisprBits
CrisprBits operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Foundation Medicine, Personalis, Novogene Corporation, MedGenome and Lantern Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| Locked | Locked | Locked |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
Detailed competitors of CrisprBits
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crisprbits
Complete news archive for CrisprBits
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CrisprBits
CrisprBits was founded in 2020 and raised its 1st funding round 2 years after it was founded.
CrisprBits is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
CrisprBits is a funded company, having raised a total of $3.45M across 3 funding rounds to date.
As of Apr 06, 2024, the latest employee count at CrisprBits is 1.
Annual revenue of CrisprBits is $29.62 as on Mar 31, 2021.
CrisprBits was founded in 2020 in Delhi, India, within the biotechnology sector. Diagnostic tests utilizing CRISPR gene editing technology are provided for infectious diseases, inherited conditions, cancer detection, and genetic disease prediction. These tools are applied in animal and cell models, agriculture, biofuels production, therapeutic development, and industrial processes. Operations focus on advancing accessible diagnostics across healthcare and related fields.
CrisprBits's top competitors include Foundation Medicine, MedGenome and Personalis.
CrisprBits offers CRISPR Diagnostics, Therapeutics Development, and Climate Applications.
CrisprBits has 10 investors. Key investors include VJ Technologies, Abilities India Pistons and Rings, Rajeev Kohli, Sunil Arora, and Aditya Sarda.
The valuation of CrisprBits is $284.02K as of May 2022.